This blog, based on IQVIAs 18th March 2026 webinar on the future of the Obesity Medicines market, looks ahead to the next phase of that transformation, examining how the obesity market evolves from 2026 to 2030, and how the drivers of success shift from rapid adoption to differentiation, longterm performance and systemlevel impact
Do GLP-1 medications affect contraception
Estudos indicam que essa associao pode contribuir para melhora da vitalidade, suporte ao metabolismo, recuperao corporal e equilbrio fisiolgico geral
The ideal medical team includes: Endocrinologist: Manages thyroid function, monitors TSH and antibodies, adjusts levothyroxine, screens for thyroid nodules and cancer risk Obesity medicine specialist or prescribing clinician: Manages GLP-1 dosing, titration, and side effects Registered dietitian: Develops nutrition plans that address both autoimmune support and adequate intake on reduced appetite Communication between these providers is essential